Turn Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Turn Therapeutics Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Revenue & Gross Profit
Revenue0.000.000.00
Cost of Revenue0.000.000.00
Gross Profit0.000.000.00
Operating Expenses
Research & Development0.250.010.00
Selling, General & Administrative1.552.304.21
Operating Expenses1.802.314.21
Operating Income-1.80-2.31-4.21
Other Income/Expense
Interest Income0.030.020.01
Interest Expense0.000.00-0.09
Other Income/Expense0.030.000.00
Income
Income Before Tax-1.77-2.29-4.29
Income Tax Expense0.000.000.00
Net Income-1.77-2.29-4.29
Net Income - Continuous Operations-1.77-2.290.00
Net Income - Discontinued Operations0.000.000.00
EBITDA-1.75-2.26-4.16
EBIT-1.80-2.31-4.21
Depreciation & Amortization0.050.040.05
Earnings Per Share
Basic EPS---
Diluted EPS---
Basic Shares Outstanding29.4526.490.00
Diluted Shares Outstanding29.4526.490.00